Discovery

Asuragen offers a broad range of proprietary chemistries along with the flexibility of using different technology platforms coupled with industry-leading, in-house bioinformatics for biomarker discovery and development. This bioinformatic-driven, platform-agnostic approach ensures we take an unbiased approach to deploy the best scientific solution to match your needs.

Our internal biomarker discovery and development has resulted in the out-licensing of several complex signatures to diagnostic partners for clinical use and our partnerships have identified signatures that have progressed from discovery stage to research assays, clinical trial assays, IUO and IVD kits.

Discovery Technologies

Leveraging an extensive scientific foundation and broad range of technologies, Asuragen continues to drive biomarker discovery both for internal purposes and to support our partners’ needs.

Discovery Platforms Exploratory Assays

 

 

 

 

 

 

 

Bioinformatics

Employing our unique bioinformatics algorithms and iterative development process we are able to support your hypothesis development and validation. Leveraging bioinformatics, in combination with our broad range of discovery technologies, we are able to provide deep interrogation of genetic library data and in-house generated assay results to enable biomarker signature selection.

Comprehensive data alayasis & interpretationPCR and sequencing-based technologies enable signatures to be developed using:
SNPs, SNV’s, INDELs and complex variants
Copy number analysis
Gene expression analysis (both RNA and miRNA)
Multi-modal assays (both RNA and DNA)

Discovery

Asuragen offers a broad range of proprietary chemistries along with the flexibility of using different technology platforms coupled with industry-leading, in-house bioinformatics for biomarker discovery and development. This bioinformatic-driven, platform-agnostic approach ensures we take an unbiased approach to deploy the best scientific solution to match your needs.

Our internal biomarker discovery and development has resulted in the out-licensing of several complex signatures to diagnostic partners for clinical use and our partnerships have identified signatures that have progressed from discovery stage to research assays, clinical trial assays, IUO and IVD kits.

Discovery Technologies

Leveraging an extensive scientific foundation and broad range of technologies, Asuragen continues to drive biomarker discovery both for internal purposes and to support our partners’ needs.

Discovery Platforms Exploratory Assays

 

 

 

 

 

 

 

Bioinformatics

Employing our unique bioinformatics algorithms and iterative development process we are able to support your hypothesis development and validation. Leveraging bioinformatics, in combination with our broad range of discovery technologies, we are able to provide deep interrogation of genetic library data and in-house generated assay results to enable biomarker signature selection.

Comprehensive data alayasis & interpretationPCR and sequencing-based technologies enable signatures to be developed using:
SNPs, SNV’s, INDELs and complex variants
Copy number analysis
Gene expression analysis (both RNA and miRNA)
Multi-modal assays (both RNA and DNA)

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close